SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Product › Details

Measles Vector (MV) technology platform

Products Next higher product group vaccine technology_o
Period Status 2018-10-29 existent
Organisation Organisation Themis Bioscience N.V.
  Group Themis Bioscience (Group)
Document Source Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna.

Record changed: 2018-11-12


Picture [LSUS] – The Business Web Portal 600x60px

More documents for vaccine technology_o

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top